What Is the First-Line Treatment of Secondary Raynaud's Phenomenon?

Secondary Raynaud's phenomenon is a vasospastic disorder occurring in the context of an underlying condition. Establishing an appropriate first-line pharmacological regimen is a central clinical priority, with dose selection and uptitration guided by patient tolerability.

Clinical Approach

First-line management involves a specific class of vasodilatory agent. Treatment is initiated at the lowest effective dose and increased gradually — the full agent selection, formulation choice, and dose escalation pathway are detailed in the complete protocol.

Treatment Overview

Calcium channel blockers are the established first-line pharmacological intervention for this condition. The structured protocol specifies which agents and formulations are indicated, how dose escalation should proceed, and at what point to reassess.

Instant Access to Structured Evidence-Based Regimens

References

Calcium channel blockers are first-line treatment.

A favoured approach is to commence a sustained-release preparation in low dose, then gradually increase the dose as tolerated.

DOI: 10.1177/1759720X17740074

View source ↗